- Home
- About
- PsychU For You
- Topics
- Mental Health Disorders
- Agitation
- Bipolar Disorder
- Depression
- Pseudobulbar Affect (PBA)
- PTSD/Trauma
- Schizophrenia
- Substance Use Disorders
- Topics of Interest
- Care Coordination
- Digital Health
- Diversity, Equity, & Inclusion
- Health Care Policy, Quality & Payer Administration
- Long-Term Care
- Stigma
- Suicide Awareness
- Wellness
- Events
- Content
- Supporting Organizations
Virtual Event – Do Inflammation & Metabolic Disturbances Metastasize to the Brain? Implications for Disease Modeling & Novel Approaches in Psychiatry

Thank You For Attending Today’s Webinar
Please tell us what you thought about today’s presentation by taking the survey below:
About This Event
Virtual Event – Do Inflammation & Metabolic Disturbances Metastasize to the Brain? Implications for Disease Modeling & Novel Approaches in Psychiatry
This is a Virtual Event for PsychU members in Alabama, Florida, Georgia, and South Carolina.
In this presentation, the objectives are to:
- Describe the importance of cognitive symptoms as psychiatric targets
- Review immune and metabolic systems associated with cognitive deficits and mood disorders
- Discuss innovative approaches that may target these systems
Featuring
-
Samuel Shillcutt, PhD
Professor Emeritus, Mercer University School of Medicine, Department of Psychiatry
-
Walter Lawhorn, PharmD (OPDC)
Regional Medical Lead
-
Rachel Self, PhD, MS (OPDC)
Medical Science Director, Neuroscience Field Medical Affairs
Speaker Samuel Shillcutt, PhD is a paid consultants for Otsuka Pharmaceutical Development & Commercialization, Inc. Speakers Walter Lawhorn, PharmD and Rachel Self, PhD, MS are employees of Otsuka Pharmaceutical Development & Commercialization, Inc.